beta

FWP

Forward Pharma A/S

Fwp

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients.

Market Cap: 232 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.forward-pharma.com

Shares Outstanding: 47.2 Million

Float: 47.2 Million

Dividend: 45.975952 (934.47%)

Beta: 3.375526

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 24.1 Thousand

Ethical Flags

Animal testing

Longest drawdown: 2489 trading days

From: 2015-06-22 To: 2019-09-13

Lowest Point:

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2019-04-04 12:36:54:000

Forward Pharma (NASDAQ: FWP ): FY GAAP EPS of -$0.09. More news on: Forward Pharma A/S, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 11:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma strikes out in challenge to Biogen Tecfidera patent; shares down 3%

via: SeekingAlpha at 2018-10-24 07:10:52:000

The U.S. Court of Appeals for the Federal Circuit affirms the decision from the USPTO's Patent Trial and Appeal Board that a Biogen ( BIIB -0.1% ) patent covering MS med Tecfidera (dimethyl fumarate) is valid, therefore rejecting Forward Pharma's ( FWP -2.8% ) challenge. The ruling a… read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2018-09-19 16:25:57:000

Forward Pharma (NASDAQ: FWP ): 1H GAAP EPS of -$0.06. More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update

via: SeekingAlpha at 2018-08-14 05:08:29:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 08/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Institutional Top Ideas Series: Biotechnology Value Fund

via: SeekingAlpha at 2018-06-04 09:19:47:000

In the last entry of this series, we took a look at top ideas from Perceptive Advisors, a hedge fund with a highly enviable track record characterized by impressive consistency and high returns. Going forward, I hope to continue to delve into the portfolios of successful hedge funds predo… read more...

Institutional Top Ideas Series: Biotechnology Value Fund

via: SeekingAlpha at 2018-06-04 09:19:47:000

In the last entry of this series, we took a look at top ideas from Perceptive Advisors, a hedge fund with a highly enviable track record characterized by impressive consistency and high returns. Going forward, I hope to continue to delve into the portfolios of successful hedge funds predo… read more...

Institutional Top Ideas Series: Biotechnology Value Fund

via: SeekingAlpha at 2018-06-04 09:19:47:000

In the last entry of this series, we took a look at top ideas from Perceptive Advisors, a hedge fund with a highly enviable track record characterized by impressive consistency and high returns. Going forward, I hope to continue to delve into the portfolios of successful hedge funds predo… read more...

Institutional Top Ideas Series: Biotechnology Value Fund

via: SeekingAlpha at 2018-06-04 09:19:47:000

In the last entry of this series, we took a look at top ideas from Perceptive Advisors, a hedge fund with a highly enviable track record characterized by impressive consistency and high returns. Going forward, I hope to continue to delve into the portfolios of successful hedge funds predo… read more...

Institutional Top Ideas Series: Biotechnology Value Fund

via: SeekingAlpha at 2018-06-04 09:19:47:000

In the last entry of this series, we took a look at top ideas from Perceptive Advisors, a hedge fund with a highly enviable track record characterized by impressive consistency and high returns. Going forward, I hope to continue to delve into the portfolios of successful hedge funds predo… read more...

Institutional Top Ideas Series: Biotechnology Value Fund

via: SeekingAlpha at 2018-06-04 09:19:47:000

In the last entry of this series, we took a look at top ideas from Perceptive Advisors, a hedge fund with a highly enviable track record characterized by impressive consistency and high returns. Going forward, I hope to continue to delve into the portfolios of successful hedge funds predo… read more...

Institutional Top Ideas Series: Biotechnology Value Fund

via: SeekingAlpha at 2018-06-04 09:19:47:000

In the last entry of this series, we took a look at top ideas from Perceptive Advisors, a hedge fund with a highly enviable track record characterized by impressive consistency and high returns. Going forward, I hope to continue to delve into the portfolios of successful hedge funds predo… read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/23/2018)

via: SeekingAlpha at 2018-05-23 12:36:45:000

Gainers: WMLP +172% . AVGR +53% . CARA +32% . BDR +28% . TIF +20% . RL +17% . MDXG +16% . AMDA +14% . USAT +13% . DCAR +13% . More news on: Westmoreland Resource Partners, LP, Avinger, Cara Therapeutics Inc., Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:10 am (5/23/2018)

via: SeekingAlpha at 2018-05-23 09:17:32:000

RRGB -20% on Q1 earnings . More news on: Red Robin Gourmet Burgers, Inc., Pfenex, Ardelyx, Stocks on the move, , Read more … read more...

After Hours Gainers / Losers (05/22/2018)

via: SeekingAlpha at 2018-05-22 17:34:42:000

Top gainers: GDS +8.3% . REN +4.3% . HK +3.3% . TUSK +3.3% . LPI +2.9% . More news on: GDS Holdings, Resolute Energy Corporation, Halcon Resources Corporation, Stocks on the move, , News on ETFs, Read more … read more...

After Hours Gainers / Losers (05/22/2018)

via: SeekingAlpha at 2018-05-22 17:34:42:000

Top gainers: GDS +8.3% . REN +4.3% . HK +3.3% . TUSK +3.3% . LPI +2.9% . More news on: GDS Holdings, Resolute Energy Corporation, Halcon Resources Corporation, Stocks on the move, , News on ETFs, Read more … read more...

After Hours Gainers / Losers (05/22/2018)

via: SeekingAlpha at 2018-05-22 17:34:42:000

Top gainers: GDS +8.3% . REN +4.3% . HK +3.3% . TUSK +3.3% . LPI +2.9% . More news on: GDS Holdings, Resolute Energy Corporation, Halcon Resources Corporation, Stocks on the move, , News on ETFs, Read more … read more...

Forward Pharma up 35%

via: SeekingAlpha at 2018-05-22 13:48:41:000

Thinly traded micro cap Forward Pharma A/S ( FWP +34.5% ) jumps on more than double normal volume, albeit on turnover of only 228K shares. No particular news accounts for the action. More news on: Forward Pharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Forward Pharma up 35%

via: SeekingAlpha at 2018-05-22 13:48:41:000

Thinly traded micro cap Forward Pharma A/S ( FWP +34.5% ) jumps on more than double normal volume, albeit on turnover of only 228K shares. No particular news accounts for the action. More news on: Forward Pharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Forward Pharma up 35%

via: SeekingAlpha at 2018-05-22 13:48:41:000

Thinly traded micro cap Forward Pharma A/S ( FWP +34.5% ) jumps on more than double normal volume, albeit on turnover of only 228K shares. No particular news accounts for the action. More news on: Forward Pharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Midday Gainers / Losers (05/22/2018)

via: SeekingAlpha at 2018-05-22 12:41:50:000

Gainers: CPAH +16% . CRMT +15% . MDXG +13% . NSTG +12% . SDR +12% . FWP +11% . ARQL +11% . GERN +11% . SMRT +11% . AVEO +10% . More news on: CounterPath Corporation, America's Car-Mart, Inc., MiMedx Group Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/22/2018)

via: SeekingAlpha at 2018-05-22 12:41:50:000

Gainers: CPAH +16% . CRMT +15% . MDXG +13% . NSTG +12% . SDR +12% . FWP +11% . ARQL +11% . GERN +11% . SMRT +11% . AVEO +10% . More news on: CounterPath Corporation, America's Car-Mart, Inc., MiMedx Group Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/22/2018)

via: SeekingAlpha at 2018-05-22 12:41:50:000

Gainers: CPAH +16% . CRMT +15% . MDXG +13% . NSTG +12% . SDR +12% . FWP +11% . ARQL +11% . GERN +11% . SMRT +11% . AVEO +10% . More news on: CounterPath Corporation, America's Car-Mart, Inc., MiMedx Group Inc., Stocks on the move, , Read more … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update

via: SeekingAlpha at 2018-05-15 10:33:51:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update

via: SeekingAlpha at 2018-05-15 10:33:51:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update

via: SeekingAlpha at 2018-05-15 10:33:51:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update

via: SeekingAlpha at 2018-05-15 10:33:51:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update

via: SeekingAlpha at 2018-05-15 10:33:51:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update

via: SeekingAlpha at 2018-05-15 10:33:51:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Seth Klarmans Baupost Group Holdings … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2018-04-30 17:25:01:000

Forward Pharma (NASDAQ: FWP ): FY EPS of $2.30 More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma reports FY results

via: SeekingAlpha at 2018-04-30 17:25:01:000

Forward Pharma (NASDAQ: FWP ): FY EPS of $2.30 More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Forward Pharma (FWP) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-02-16 12:35:48:000

The following slide deck was published by Forward Pharma in conjunction with this Read more … read more...

Forward Pharma (FWP) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-02-16 12:35:48:000

The following slide deck was published by Forward Pharma in conjunction with this Read more … read more...

Forward Pharma (FWP) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-02-16 12:35:48:000

The following slide deck was published by Forward Pharma in conjunction with this Read more … read more...

Forward Pharma (FWP) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-02-16 12:35:48:000

The following slide deck was published by Forward Pharma in conjunction with this Read more … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update

via: SeekingAlpha at 2018-02-14 08:57:59:000

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 02/13/2018. Please visit our Tracking Seth Klarmans Baupost Group Holding… read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Your Daily Pharma Scoop: Abeona's EB-101 Granted RMAT Designation, Teva To Raise Debt, Pfizer Reports Results

via: SeekingAlpha at 2018-01-31 08:00:00:000

Analysis of top Seeking Alpha coverage: Abeona Today we will discuss the update from Abeona Therapeutics ( ABEO ) with regard to its lead candidate EB-101. Abeona announced on Tuesday that the FDA granted the Regenerative Medicine Advanced Therapy ((RMAT)) designation to EB-101, the Com… read more...

Your Daily Pharma Scoop: Abeona's EB-101 Granted RMAT Designation, Teva To Raise Debt, Pfizer Reports Results

via: SeekingAlpha at 2018-01-31 08:00:00:000

Analysis of top Seeking Alpha coverage: Abeona Today we will discuss the update from Abeona Therapeutics ( ABEO ) with regard to its lead candidate EB-101. Abeona announced on Tuesday that the FDA granted the Regenerative Medicine Advanced Therapy ((RMAT)) designation to EB-101, the Com… read more...

Your Daily Pharma Scoop: Abeona's EB-101 Granted RMAT Designation, Teva To Raise Debt, Pfizer Reports Results

via: SeekingAlpha at 2018-01-31 08:00:00:000

Analysis of top Seeking Alpha coverage: Abeona Today we will discuss the update from Abeona Therapeutics ( ABEO ) with regard to its lead candidate EB-101. Abeona announced on Tuesday that the FDA granted the Regenerative Medicine Advanced Therapy ((RMAT)) designation to EB-101, the Com… read more...

Midday Gainers / Losers (1/29/2018)

via: SeekingAlpha at 2018-01-29 12:45:04:000

Gainers: IMMR +47% . KS +30% . OSN +28% . DPS +23% . MATX +23% . CVO +22% . BLDP +18% . AKCA +15% . PTGX +14% . KDMN +13% . More news on: Immersion Corporation, KapStone Paper and Packaging Corporation, Ossen Innovation Co., Ltd., Stocks on the move, Re… read more...

Midday Gainers / Losers (1/29/2018)

via: SeekingAlpha at 2018-01-29 12:45:04:000

Gainers: IMMR +47% . KS +30% . OSN +28% . DPS +23% . MATX +23% . CVO +22% . BLDP +18% . AKCA +15% . PTGX +14% . KDMN +13% . More news on: Immersion Corporation, KapStone Paper and Packaging Corporation, Ossen Innovation Co., Ltd., Stocks on the move, Re… read more...

Midday Gainers / Losers (1/29/2018)

via: SeekingAlpha at 2018-01-29 12:45:04:000

Gainers: IMMR +47% . KS +30% . OSN +28% . DPS +23% . MATX +23% . CVO +22% . BLDP +18% . AKCA +15% . PTGX +14% . KDMN +13% . More news on: Immersion Corporation, KapStone Paper and Packaging Corporation, Ossen Innovation Co., Ltd., Stocks on the move, Re… read more...

Forward Pharma loses challenge to European patent covering dimethyl fumarate, Tecfidera royalties at risk, appeal planned; shares down 14%

via: SeekingAlpha at 2018-01-29 11:17:59:000

The European Patent Office has revoked Forward Pharma A/S's ( FWP -13.8% ) EP 2801355 patent ('355 patent) following challenges from several parties. The company says its is disappointed with the decision and plans to appeal. More news on: Forward Pharma, Biogen Inc., Healthcare stoc… read more...

Forward Pharma loses challenge to European patent covering dimethyl fumarate, Tecfidera royalties at risk, appeal planned; shares down 14%

via: SeekingAlpha at 2018-01-29 11:17:59:000

The European Patent Office has revoked Forward Pharma A/S's ( FWP -13.8% ) EP 2801355 patent ('355 patent) following challenges from several parties. The company says its is disappointed with the decision and plans to appeal. More news on: Forward Pharma, Biogen Inc., Healthcare stoc… read more...

Forward Pharma loses challenge to European patent covering dimethyl fumarate, Tecfidera royalties at risk, appeal planned; shares down 14%

via: SeekingAlpha at 2018-01-29 11:17:59:000

The European Patent Office has revoked Forward Pharma A/S's ( FWP -13.8% ) EP 2801355 patent ('355 patent) following challenges from several parties. The company says its is disappointed with the decision and plans to appeal. More news on: Forward Pharma, Biogen Inc., Healthcare stoc… read more...

Stocks To Watch: Tech Giants In The Spotlight

via: SeekingAlpha at 2018-01-27 08:43:44:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Apple (AAPL) headlines a huge week of earnings reports from tech majors as investor… read more...

Stocks To Watch: Tech Giants In The Spotlight

via: SeekingAlpha at 2018-01-27 08:43:44:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Apple (AAPL) headlines a huge week of earnings reports from tech majors as investor… read more...

Stocks To Watch: Tech Giants In The Spotlight

via: SeekingAlpha at 2018-01-27 08:43:44:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Apple (AAPL) headlines a huge week of earnings reports from tech majors as investor… read more...

Stocks To Watch: Tech Giants In The Spotlight

via: SeekingAlpha at 2018-01-27 08:43:44:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Apple (AAPL) headlines a huge week of earnings reports from tech majors as investor… read more...

Stocks To Watch: Tech Giants In The Spotlight

via: SeekingAlpha at 2018-01-27 08:43:44:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Apple (AAPL) headlines a huge week of earnings reports from tech majors as investor… read more...

Midday Gainers / Losers (1/26/2018)

via: SeekingAlpha at 2018-01-26 12:40:10:000

Gainers: BSPM +66% . OASM +48% . CAPR +25% . RDHL +19% . ABAX +18% . PULM +18% . WRLD +16% . VMW +14% . FWP +14% . MYSZ +13% . More news on: Biostar Pharmaceutic, Oasmia Pharmaceutical, Capricor Therapeutics, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/26/2018)

via: SeekingAlpha at 2018-01-26 12:40:10:000

Gainers: BSPM +66% . OASM +48% . CAPR +25% . RDHL +19% . ABAX +18% . PULM +18% . WRLD +16% . VMW +14% . FWP +14% . MYSZ +13% . More news on: Biostar Pharmaceutic, Oasmia Pharmaceutical, Capricor Therapeutics, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/26/2018)

via: SeekingAlpha at 2018-01-26 12:40:10:000

Gainers: BSPM +66% . OASM +48% . CAPR +25% . RDHL +19% . ABAX +18% . PULM +18% . WRLD +16% . VMW +14% . FWP +14% . MYSZ +13% . More news on: Biostar Pharmaceutic, Oasmia Pharmaceutical, Capricor Therapeutics, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/26/2018)

via: SeekingAlpha at 2018-01-26 12:40:10:000

Gainers: BSPM +66% . OASM +48% . CAPR +25% . RDHL +19% . ABAX +18% . PULM +18% . WRLD +16% . VMW +14% . FWP +14% . MYSZ +13% . More news on: Biostar Pharmaceutic, Oasmia Pharmaceutical, Capricor Therapeutics, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/26/2018)

via: SeekingAlpha at 2018-01-26 12:40:10:000

Gainers: BSPM +66% . OASM +48% . CAPR +25% . RDHL +19% . ABAX +18% . PULM +18% . WRLD +16% . VMW +14% . FWP +14% . MYSZ +13% . More news on: Biostar Pharmaceutic, Oasmia Pharmaceutical, Capricor Therapeutics, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/26/2018)

via: SeekingAlpha at 2018-01-26 12:40:10:000

Gainers: BSPM +66% . OASM +48% . CAPR +25% . RDHL +19% . ABAX +18% . PULM +18% . WRLD +16% . VMW +14% . FWP +14% . MYSZ +13% . More news on: Biostar Pharmaceutic, Oasmia Pharmaceutical, Capricor Therapeutics, Inc., Stocks on the move, Read more … read more...

The Ideal Stock Evaluation System?

via: SeekingAlpha at 2018-01-22 07:26:55:000

About two and a half years ago, I had a revelation. Id been losing money for years, choosing the wrong stocks, buying and selling them at the wrong times. But I suddenly realized that the key to success in the stock market is not just screening stocks on a few factors but instead to sy… read more...

Value Strategy Update: 6% Return In 4 Months

via: SeekingAlpha at 2018-01-10 15:38:25:000

Back in July last year, we published Building A Better Value Strategy , an article that outlined a data-driven trading strategy that invested in companies with improving earnings and dividend distributions and that were cheap compared to their cash flows and sales figures. The strategy backte… read more...

Rethinking Free Cash Flow

via: SeekingAlpha at 2018-01-07 03:37:47:000

The term free cash flow has a rather curious history, with a variety of shifting meanings over the last thirty-odd years. It has always carried the meaning of cash flow in excess of that required for operations, but the nuances, implications, and use of the term have undergone … read more...

My Favorite Balance Sheet Ratio

via: SeekingAlpha at 2017-12-20 10:02:59:000

In this piece I want to drill down deep into a ratio that I find extremely useful in assessing potential investments: the ratio of net operating assets (NOA) to total assets (the lower, the better). Its my favorite balance-sheet ratio. In a 2004 paper entitled Do Investors … read more...

Tracking Seth Klarman's Baupost Group Holdings - Q3 2017 Update

via: SeekingAlpha at 2017-11-14 04:10:22:000

This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarmans regulatory 13F Form filed on 11/13/2017. Please visit our Tracking Seth Klarmans Baupost Group Holdings… read more...

Your Daily Pharma Scoop: Celgene's CELMoD Potential, Allergan's Senate Troubles, Abbott Approval Surge

via: SeekingAlpha at 2017-09-28 06:06:21:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Celgene, by Dr Udaya Maiya, MD, Oncologis… read more...

Your Daily Pharma Scoop: Nektar's Potential, Axovant Finally Fails, PTCT AdComm Tomorrow

via: SeekingAlpha at 2017-09-27 10:12:43:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Nektar Therapeutics Todays cov… read more...

Forward Pharma H1 top line $1.25B on Biogen settlement, EPS $1.91; shares up 5% after hours

via: SeekingAlpha at 2017-09-26 16:48:04:000

Forward Pharma A/S (NASDAQ: FWP ) H1 results ($M): Revenue (Biogen settlement): $1,250.0; Net Income: 1,213.0; EPS: 1.91. More news on: Forward Pharma, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more … read more...

Forward Pharma reports 1H results

via: SeekingAlpha at 2017-09-26 16:20:55:000

Forward Pharma (NASDAQ: FWP ): 1H EPS of $1.91 Revenue of $1.25M Press Release More news on: Forward Pharma, Earnings news and commentary, Healthcare stocks news, read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2017-09-12 2017-09-11 2017-09-07 23.073008 EX Dividend income
2017-09-06 2017-09-11 2017-09-07 22.902945 EX Dividend income
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud